Ronald A. Pepin

Corporate Officer/Principal bei CELLDEX THERAPEUTICS, INC.

Vermögen: - $ am 31.03.2024

68 Jahre

Health Technology

Consumer Services

Commercial Services

Aktive Positionen von Ronald A. Pepin

Unternehmen	Position	Beginn	Ende
CELLDEX THERAPEUTICS, INC.	Corporate Officer/Principal	08.07.2011	-
Antyra, Inc. Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ.	Director/Board Member	-	-

Unternehmen	Position	Beginn	Ende
Medarex, Inc. Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey.	Corporate Officer/Principal	01.08.2000	01.01.2009
BRISTOL-MYERS SQUIBB COMPANY	Chief Tech/Sci/R&D Officer	01.03.1990	01.07.2000
Shire Pharmaceuticals, Inc. Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA	Corporate Officer/Principal	-	-

Tufts University	Undergraduate Degree
Georgetown University	Doctorate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1
Undergraduate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
CELLDEX THERAPEUTICS, INC.	Health Services

Private Unternehmen	3
Medarex, Inc. Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey.	Commercial Services
Shire Pharmaceuticals, Inc. Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA	Health Technology
Antyra, Inc. Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ.	Health Technology